Breaking News
January 23, 2019 - New certified reference material for testing residual solvents in cannabis
January 23, 2019 - Gene-edited chickens could prevent future flu pandemic
January 23, 2019 - Cardiovascular disease risk begins even before birth
January 23, 2019 - Younger patients receiving kidney transplant more likely to live longer, shows data
January 23, 2019 - Skin samples hold early signs of prion disease, research suggests
January 23, 2019 - Researchers discover how body initiates repair mechanisms that limits damage to myelin sheath
January 23, 2019 - Fecal transplant from certain donors better than others
January 23, 2019 - Risk for Uninsurance in AMI Patients Reduced With Medicaid Expansion
January 23, 2019 - Readmissions reduction program may be associated with increase in patient-level mortality
January 23, 2019 - Fostering translation and communication in medicine and beyond
January 23, 2019 - To Fight Fatty Liver, Avoid Sugary Foods and Drinks
January 23, 2019 - TPU scientists develop new implants that double the rate of bone lengthening in kids
January 23, 2019 - New sessions at Pittcon 2019
January 23, 2019 - Insilico to present latest findings in AI for Drug Discovery at 3rd Annual SABPA FTD Forum
January 23, 2019 - Opioid overdose patients can be safely discharged an hour after administration of naloxone
January 23, 2019 - Scientists find bacterial extracellular vesicles in human blood
January 23, 2019 - Researchers gain new insights into development of necrotizing enterocolitis in preemies
January 23, 2019 - Medical expert advises people with epilepsy not to stockpile medicines
January 23, 2019 - Study outlines research priorities for improving pediatric patient care and safety
January 23, 2019 - Bedfont to exhibit NObreath FeNO monitor at Arab Health 2019
January 23, 2019 - Nicotinamide riboside supplementation confers significant physiological benefits to mothers and offspring
January 23, 2019 - Increasing temperatures may help preserve crop nutrition
January 23, 2019 - Many Oncologists in the Dark About LGBTQ Health Needs
January 23, 2019 - Epigenetic change causes fruit fly babies to inherit diet-induced heart disease
January 23, 2019 - Erasing memories could reduce relapse rates among drug addicts
January 23, 2019 - African Americans who smoke cigarettes are more likely to develop peripheral artery disease
January 23, 2019 - Unique data combination helps FinnGen researchers to fund links between genetic factors and health
January 23, 2019 - Parents’ mental health problems associated with reactive attachment disorder in children
January 23, 2019 - Graphene Flagship project studies impact of graphene and related materials on our health
January 23, 2019 - The connection between the Pope and contraceptive pills
January 23, 2019 - Prior dengue infection could protect children from symptomatic Zika
January 23, 2019 - Previous dengue virus infection associated with protection from symptomatic Zika
January 23, 2019 - VISTA checkpoint implicated in pancreatic cancer immunotherapy resistance
January 23, 2019 - The Tiny Camera That Could Revolutionize Cardiovascular Surgery
January 23, 2019 - Peptide isolated from soil fungi has antitumor and antibacterial properties
January 23, 2019 - TGen identifies polio-like virus as potential cause of Acute Flaccid Myelitis outbreak
January 23, 2019 - Migrants and refugees do not bring disease and are at greater health risk themselves says WHO
January 23, 2019 - Examing the effects of menopause in workplace
January 23, 2019 - Enemy number 1 – Air pollution and climate change top of WHO agenda
January 23, 2019 - Two Positive Phase III studies of Tafenoquine for the Radical Cure of Plasmodium vivax Malaria Published in The New England Journal of Medicine
January 23, 2019 - World Trade Center responders at increased risk for head and neck cancers
January 23, 2019 - Low-sugar diet leads to significant improvement in nonalcoholic fatty liver disease in boys
January 23, 2019 - Chaos in bodily regulation can optimize our immune system, finds study
January 23, 2019 - Short, text-based exercises can increase happiness for adults recovering from substance use disorders
January 23, 2019 - Body size may have greater influence on women’s lifespan than men
January 23, 2019 - Groundbreaking tool helps visualize neuronal activity with near-infrared light
January 23, 2019 - Prior dengue immunity in children may be protective against symptomatic Zika
January 23, 2019 - Holocaust survivors with PTSD and their offspring exhibit more unhealthy behavior patterns
January 23, 2019 - Scientists discover new genetic mutations causing inherited deaf-blindness
January 23, 2019 - UC team designs new naloxone-dispensing smart device
January 23, 2019 - Torrent Pharmaceuticals Limited Issues Voluntary Nationwide Recall of Losartan Potassium Tablets, USP and Losartan Potassium and Hydrochlorothiazide Tablets, USP
January 23, 2019 - Brain activity shows development of visual sensitivity in autism
January 23, 2019 - Two hour gap between dinner and sleep is overrated says Japanese research
January 23, 2019 - Fear and embarrassment are causing smear test numbers to plummet
January 23, 2019 - Protein-secreting device implanted in epileptic rats reduces seizures, improves cognition
January 23, 2019 - Reintroduction project recovers current wild population of green turtle in Cayman Islands
January 23, 2019 - Cancer survivors face greater financial burden related to medical bills
January 23, 2019 - PSA screening reduces prostate cancer deaths by 30%
January 23, 2019 - LSTM receives grant to help improve health of people living in informal settlements
January 23, 2019 - Hemochromatosis Mutation Linked to Other Morbidity
January 23, 2019 - Why early diagnosis of autism should lead to early intervention
January 23, 2019 - Aspirin May Lower Stroke Risk in Women with History of Preeclampsia
January 23, 2019 - Exposure to certain chemicals may be linked to decrease in blood pressure during pregnancy
January 23, 2019 - Bowel cancer on the rise among younger Australians
January 23, 2019 - Scientists have reversed memory loss in a mouse model of Alzheimer’s
January 23, 2019 - Defective molecular master switch could lead to age-related macular degeneration
January 23, 2019 - Researchers identify how concussions may contribute to seizures
January 23, 2019 - Short interval between last meal of the day and bedtime may not affect blood glucose levels
January 23, 2019 - Still Too Many Highway Deaths Tied to Speeding
January 23, 2019 - Prenatal valproate exposure linked to increased ADHD risk
January 23, 2019 - Compound identified that may help treat heart failure
January 23, 2019 - Undiagnosed Asthma in Urban Adolescents May Be Common
January 23, 2019 - Study describes metabolism of intestinal microbiota in babies for the first time
January 22, 2019 - Study links concussions to development of epilepsy
January 22, 2019 - Specialist-led hospital bereavement service may help restrain legal action after difficult deaths
January 22, 2019 - Genetic study reveals possible new routes to treating osteoarthritis
January 22, 2019 - Blood test may detect early signs of lung-transplant rejection
January 22, 2019 - Blood marker could aid in early prediction of Alzheimer’s progression
January 22, 2019 - Orthodontic treatment does not guarantee future dental health
January 22, 2019 - Rutgers researchers discover cause of bone loss in people with joint replacements
Broader Group May Benefit from Late Thrombectomy

Broader Group May Benefit from Late Thrombectomy

image_pdfDownload PDFimage_print

LOS ANGELES — An extended window for endovascular thrombectomy appears safe for a broader range of acute ischemic stroke patients, with improved outcomes over medical therapy alone, researchers found in the DEFUSE 3 trial.

When performed 6 to 16 hours after patients were last known well and had favorable brain perfusion characteristics, stent retriever use along with medical therapy reduced death and disability, with a 2.77-fold greater odds that modified Rankin scale score at 90 days would be shifted favorably (P<0.001).

Good functional outcome — survival to be independent in activities of daily living, modified Rankin scale of 0 to 2 — favored thrombectomy as well (45% versus 17%, P<0.001), Gregory Albers, MD, of Stanford University in California, and colleagues reported here at the International Stroke Conference, with the data published simultaneously online in the New England Journal of Medicine.

Combination treatment held a numerical advantage over use of medical therapy alone for 90-day mortality (14% versus 26%, P=0.05).

The biggest adverse event concern — symptomatic intracranial hemorrhage — was not significantly worse with thrombectomy than without it (7% versus 4%, P=0.75). Serious adverse events overall were similar between groups (43% versus 53%, P=0.18).

“Previous trials of endovascular treatment of acute stroke have suggested that a limited proportion of patients had a favorable clinical outcome when reperfusion was instituted later than 7 or 8 hours after stroke onset,” the researchers noted.

However, the DAWN trial subsequently showed an advantage of thrombectomy for outcomes in patients treated with wake-up strokes and those presenting 6 to 24 hours after last time known well.

“Our findings confirm and extend those of the DAWN trial, which used the same automated perfusion software (RAPID) as in our trial to measure the volume of the early infarct and to measure hypoperfused volume,” Albers et al added.

Broader Criteria

DAWN used somewhat narrower selection criteria, with smaller core infarctions than those in DEFUSE 3, with participants in DAWN also having more severe stroke symptoms. About 40% of DEFUSE 3 participants would not have met the DAWN selection criteria, Albers’s group noted.

“This is as exciting as Nashville,” commented Bruce Campbell, MBBS, PhD, of Australia’s Royal Melbourne Hospital — referring to the panel of trials presented there at the 2015 Stroke conference that created the mandate for mechanical thrombectomy in this type of stroke by confirming the initial positive results from the MR CLEAN trial. “We’ve been working toward this for 20 years.”

DEFUSE 3 is an advance because the criteria are broader and easier to remember, Campbell said, which he expects to increase the number of patients that can be treated.

Remarkably, DAWN and DEFUSE 3 have had bigger treatment effects than seen in the 6-hour trials, apparently because of the poor outcomes of those treated medically outside the standard window for thrombolytics.

“We were really astounded to see the spectacular results from this study,” Albers said at a press conference for the late-breaking clinical trial session, noting that the the odds ratio found for the primary outcome in DEFUSE 3 was “the largest odds ratio ever reported for a thrombectomy study, so it indicates a major shift.”

Selection criteria likely also played a role, because patients had scans showing tissue that was ischemic but not yet infarcted and thus potentially salvageable, the researchers said.

A separate analysis presented at the session looking at numbers needed to treat and other metrics of individual-level benefit by Jeffrey Saver, MD, of UCLA, showed a number needed to treat of just two in DAWN.

For every 100 patients treated with mechanical thrombecomy as in DAWN, 50 would have improved disability-related quality of life, including functional independence in 36 of them.

The same was true for the early (6 to 12 hours) and later (more than 12 up to 24 hours) time windows considered separately, with about half of patients benefitting in both periods. But the shift was to lesser degrees of disability in the earlier- than in the later-treated group, emphasizing the importance of treating as soon as possible, Saver noted.

In DEFUSE 3, the results were similar, with 48 of every 100 patients treated having lower disability with thrombectomy.

“A new era dawned with DAWN and now with DEFUSE it can diffuse out there, so it’s a nice matched set,” Saver quipped at a press briefing.

Consistent Results

The open-label DEFUSE 3 trial included 182 patients with proximal middle-cerebral-artery or internal-carotid-artery occlusion who were deemed eligible due to initial infarct volume under 70 mL, a ratio of ischemic tissue volume to initial infarct volume of at least 1.8, and an absolute penumbra of at least 15 ml by either CT perfusion or MRI diffusion. The trial was stopped early for efficacy.

While treatment up to 16 hours after last known well time, including wake-up strokes, was allowed, the median from symptom onset to baseline imaging was 10 hours 29 minutes, with a quarter occurring after 11 hours 40 minutes.

Early termination of the trial before full enrollment limited its power for subgroup comparisons, the researchers cautioned. However, given that, “the beneficial effect of endovascular therapy was consistent in patients with a known time of stroke onset and those with an unknown time of onset, in patients treated 9 to 12 hours after onset and those treated more than 12 hours after onset (but not those treated <9 hours after onset), and in patients selected on the basis of diffusion and perfusion MRI and those selected on the basis of CT perfusion imaging."

In the group of 50 patients treated between 6 and 9 hours after stroke symptoms were discovered, the odds of functional independence favored thrombectomy, but not significantly so (RR 1.43, 95% CI 0.65-3.15).

General anesthesia, which has been controversial with thrombectomy, was used in 26 patients (28%).

The trial was funded by the National Institute of Neurological Disorders and Stroke.

Albers reported a financial relationship with iSchemaView, personal fees from Medtronic outside DEFUSE 3, and a patent licensed to Stanford University for automated detection of arterial input function and venous output function voxels in medical imaging.

2018-01-24T14:20:00-0500

Tagged with:

About author

Related Articles